Akso Health (AHG) Preferred Stock Liabilities (2025)
Akso Health (AHG) reported Preferred Stock Liabilities of $256330.0 for Q3 2025, up 55.47% quarter-over-quarter from $164877.0 in Q1 2025.
Akso Health (AHG) Preferred Stock Liabilities (2025) Analysis & Trends
Akso Health has reported Preferred Stock Liabilities for 1 years, with the latest figure at $256330.0 in Q3 2025.
- For the quarter ending Q3 2025, Preferred Stock Liabilities changed N/A year-over-year to $256330.0; the trailing twelve-month figure through Sep 2025 stood at $256330.0 (changed N/A YoY), and the FY2025 full-year result was $164877.0, changed N/A from the prior year.
- Preferred Stock Liabilities for Q3 2025 stood at $256330.0, up from $164877.0 in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $256330.0 in Q3 2025, with the low at $164877.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 256,330.00 |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | - |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | - |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | - |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | - |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | - |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | - |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | - |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 256,330.00 |
| Mar 31, 2025 | 164,877.00 |